ERIE, CO – Building on its pioneering leadership in space biology, Sachi Bio today announced the award of a prestigious NASA InSPA (In Space Production Applications) Phase 2 contract . This milestone follows the successful completion of the InSPA Phase 1 contract , further accelerating the development of Sachi Bio’s proprietary Nanoligomer™ platform—a programmable RNA therapeutic discovery engine designed to tackle the world's most devastating conditions, from ALS and Alzhe
